India to Ireland: Meloxicam Export Trade Route
India has recorded 95 verified shipments of Meloxicam exported to Ireland, representing a combined trade value of $1.1M USD. This corridor is served by 4 active Indian exporters, with an average shipment value of $11.8K USD. The leading Indian exporter is UNICHEM LABORATORIES LIMITED, which accounts for 69% of total export value with 29 shipments worth $780.2K USD. On the buying side, NICHE GENERICS LTD. is the largest importer in Ireland with $610.8K USD in purchases. The top 3 suppliers — UNICHEM LABORATORIES LIMITED, CIPLA LIMITED, CIPLA LIMITED — together control 91% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Ireland Meloxicam corridor is one of India's established pharmaceutical export routes, with 95 shipments documented worth a combined $1.1M USD. The route is dominated by UNICHEM LABORATORIES LIMITED, which alone accounts for roughly 69% of all export value, reflecting the consolidated nature of India's meloxicam manufacturing sector.
Across 4 active suppliers, the average shipment value stands at $11.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with meloxicam's non-urgent bulk-order profile.
Shipment activity peaks during April-June, with an average transit time of 30 days port-to-port. The route has recorded an annual growth rate of 27.3%, placing it at rank #15 among India's top meloxicam export destinations globally.
On the import side, key buyers of Indian meloxicam in Ireland include NICHE GENERICS LTD., NICHE GENERICS LTD, CHANELLE MEDICAL and 6 others. NICHE GENERICS LTD. is the single largest importer with 14 shipments valued at $610.8K USD.
